International scientific panel
Erik de Clercq
Member of the International scientific panel, Biology
"A pioneer in antiviral research, Dr. Erik De Clercq (1941) began his medical career in 1966, received his certification in Clinical Pathology in 1971, and his Ph.D. the following year. While at the Rega Institute for Medical Research, he led teams that discovered some of the first anti-HIV medications and played a central role in developing the paradigm-shifting concept of combination therapy for HIV, which today is the most effective treatment strategy for HIV/AIDS patients. Over his prodigious career, Dr. De Clercq’s research focused on the development of new therapies, and in particular, the development of new agents against viral infections. He is widely recognized for his seminal work in the field of nucleotide analogs, which were the first broad-spectrum antivirals, and sparked a new era in antiviral development."
Quote from the Dr. Paul Janssen Award for Medical Research